Global Immunology Market Overview:
Global Immunology Market is expected to grow at a significant rate during the forecast period 2026-2035, with 2024 as the base year.
Global Immunology Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Immunology involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Immunology Market:
The Immunology Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Immunology Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Immunology Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Immunology market has been segmented into:
Monoclonal Antibody (mAb
By Application, Immunology market has been segmented into:
Rheumatoid Arthritis
Psoriatic Arthritis
Plaque Psoriasis
Ankylosing Spondylitis
Inflammatory Bowel Disease
Prophylaxis of Organ Rejection
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Immunology market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Immunology market.
Top Key Players Covered in Immunology market are:
AbbVie Inc.
Johnson & Johnson
Amgen Inc.
F. Hoffmann-La Roche Ltd
Pfizer Inc.
Novartis International AG
Bristol-Myers Squibb Company
Merck & Co.
Inc.
AstraZeneca PLC
Sanofi
GlaxoSmithKline plc
UCB S.A.
Eli Lilly and Company
Gilead Sciences Inc.
Celgene Corporation
Biogen Inc.
Regeneron Pharmaceuticals Inc.
Teva Pharmaceutical Industries Ltd.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Immunology Market by Type
4.1 Immunology Market Snapshot and Growth Engine
4.2 Immunology Market Overview
4.3 Monoclonal Antibody (mAb
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Monoclonal Antibody (mAb: Geographic Segmentation Analysis
Chapter 5: Immunology Market by Application
5.1 Immunology Market Snapshot and Growth Engine
5.2 Immunology Market Overview
5.3 Rheumatoid Arthritis
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Rheumatoid Arthritis: Geographic Segmentation Analysis
5.4 Psoriatic Arthritis
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Psoriatic Arthritis: Geographic Segmentation Analysis
5.5 Plaque Psoriasis
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Plaque Psoriasis: Geographic Segmentation Analysis
5.6 Ankylosing Spondylitis
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Ankylosing Spondylitis: Geographic Segmentation Analysis
5.7 Inflammatory Bowel Disease
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Inflammatory Bowel Disease: Geographic Segmentation Analysis
5.8 Prophylaxis of Organ Rejection
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 Prophylaxis of Organ Rejection: Geographic Segmentation Analysis
5.9 Others
5.9.1 Introduction and Market Overview
5.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.9.3 Key Market Trends, Growth Factors and Opportunities
5.9.4 Others: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Immunology Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 ABBVIE INC.
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 JOHNSON & JOHNSON
6.4 AMGEN INC.
6.5 F. HOFFMANN-LA ROCHE LTD
6.6 PFIZER INC.
6.7 NOVARTIS INTERNATIONAL AG
6.8 BRISTOL-MYERS SQUIBB COMPANY
6.9 MERCK & CO.
6.10 INC.
6.11 ASTRAZENECA PLC
6.12 SANOFI
6.13 GLAXOSMITHKLINE PLC
6.14 UCB S.A.
6.15 ELI LILLY AND COMPANY
6.16 GILEAD SCIENCES INC.
6.17 CELGENE CORPORATION
6.18 BIOGEN INC.
6.19 REGENERON PHARMACEUTICALS INC.
6.20 TEVA PHARMACEUTICAL INDUSTRIES LTD.
Chapter 7: Global Immunology Market By Region
7.1 Overview
7.2. North America Immunology Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Monoclonal Antibody (mAb
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Rheumatoid Arthritis
7.2.5.2 Psoriatic Arthritis
7.2.5.3 Plaque Psoriasis
7.2.5.4 Ankylosing Spondylitis
7.2.5.5 Inflammatory Bowel Disease
7.2.5.6 Prophylaxis of Organ Rejection
7.2.5.7 Others
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Immunology Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Monoclonal Antibody (mAb
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Rheumatoid Arthritis
7.3.5.2 Psoriatic Arthritis
7.3.5.3 Plaque Psoriasis
7.3.5.4 Ankylosing Spondylitis
7.3.5.5 Inflammatory Bowel Disease
7.3.5.6 Prophylaxis of Organ Rejection
7.3.5.7 Others
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Immunology Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Monoclonal Antibody (mAb
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Rheumatoid Arthritis
7.4.5.2 Psoriatic Arthritis
7.4.5.3 Plaque Psoriasis
7.4.5.4 Ankylosing Spondylitis
7.4.5.5 Inflammatory Bowel Disease
7.4.5.6 Prophylaxis of Organ Rejection
7.4.5.7 Others
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Immunology Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Monoclonal Antibody (mAb
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Rheumatoid Arthritis
7.5.5.2 Psoriatic Arthritis
7.5.5.3 Plaque Psoriasis
7.5.5.4 Ankylosing Spondylitis
7.5.5.5 Inflammatory Bowel Disease
7.5.5.6 Prophylaxis of Organ Rejection
7.5.5.7 Others
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Immunology Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Monoclonal Antibody (mAb
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Rheumatoid Arthritis
7.6.5.2 Psoriatic Arthritis
7.6.5.3 Plaque Psoriasis
7.6.5.4 Ankylosing Spondylitis
7.6.5.5 Inflammatory Bowel Disease
7.6.5.6 Prophylaxis of Organ Rejection
7.6.5.7 Others
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Immunology Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Monoclonal Antibody (mAb
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Rheumatoid Arthritis
7.7.5.2 Psoriatic Arthritis
7.7.5.3 Plaque Psoriasis
7.7.5.4 Ankylosing Spondylitis
7.7.5.5 Inflammatory Bowel Disease
7.7.5.6 Prophylaxis of Organ Rejection
7.7.5.7 Others
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Immunology Scope:
|
Report Data
|
Immunology Market
|
|
Immunology Market Size in 2025
|
USD XX million
|
|
Immunology CAGR 2025 - 2032
|
XX%
|
|
Immunology Base Year
|
2024
|
|
Immunology Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
AbbVie Inc., Johnson & Johnson, Amgen Inc., F. Hoffmann-La Roche Ltd, Pfizer Inc., Novartis International AG, Bristol-Myers Squibb Company, Merck & Co., Inc., AstraZeneca PLC, Sanofi, GlaxoSmithKline plc, UCB S.A., Eli Lilly and Company, Gilead Sciences Inc., Celgene Corporation, Biogen Inc., Regeneron Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd..
|
|
Key Segments
|
By Type
Monoclonal Antibody (mAb
By Applications
Rheumatoid Arthritis
Psoriatic Arthritis
Plaque Psoriasis
Ankylosing Spondylitis
Inflammatory Bowel Disease
Prophylaxis of Organ Rejection
Others
|
